ArticleMedicine2025
Crescentic glomerulonephritis associated with NK-large granular lymphocytic leukemia: A case report.
Article in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
rationaleChronic lymphoproliferative disorder of natural killer cells is a rare heterogeneous indolent hematological disease, characterized by persistent clonal increase of mature NK cells with a typical large granular lymphocyte pattern. Chronic lymphoproliferative disorder of natural killer cells was revised to NK-large granular lymphocytic leukemia (NK-LGLL) in 2022 WHO classification. Renal involvement in NK-LGLL is extremely rare. Here, we report a woman diagnosed with NK-LGLL and nephrotic syndrome. PATIENT CONCERNS: A 54-year-old woman had no obvious symptoms except for persistent peripheral lymphocytosis and neutropenia before kidney involvement. Then she presented with nephrotic syndrome, acute kidney injury and Epstein-Barr virus infection. DIAGNOSES: Bone marrow displayed clonal increase of mature NK cells with a typical large granular lymphocyte pattern. Renal biopsy showed pauci-immune crescentic glomerulonephritis and renal infiltration by NK-LGLL after exclusion of other diseases. Pathogenic N642H mutation of STAT5B was detected by targeted exome sequencing. A319T mutation in RELN and R500W mutation in INTS1 were also identified. Hence, she was diagnosed with crescentic glomerulonephritis associated with NK-LGLL. INTERVENTIONS AND OUTCOME: We planned to combine methylprednisolone and cyclophosphamide in the treatment of this case. Unfortunately, our patient died of severe cerebral hemorrhage shortly after the diagnosis of NK-LGLL. We had no opportunity to use immunosuppressive drugs for therapy. LESSONS: In short, we report a unique case diagnosed with crescentic glomerulonephritis associated with NK-LGLL, with pathogenic N642H mutation in STAT5B, Epstein-Barr virus infection and poor prognosis, different from typical inert type. Close monitoring of renal function is suggested for similar NK-LGLL patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.